Wael Kaskas has been designated as General Manager for Haleon in Hungary, Romania, Czechia, and Slovakia.
In a strategic move aimed at bolstering Haleon's presence in key emerging markets, the global consumer healthcare company has appointed Wael Kaskas as the General Manager for its cluster covering Hungary, Romania, Czechia, and Slovakia.
With a diverse product range spanning oral health, pain relief, respiratory health, digestive care, and vitamins and supplements, Kaskas' role encompasses managing Haleon's operations across these four Central European countries. His key focus appears to be leading Haleon's expansion and innovation in the health and wellness sectors, with strategies likely emphasizing portfolio growth, innovation in supplements, and strengthening brand presence in these markets.
Kaskas brings a wealth of experience to his new role, having previously held a position responsible for marketing and strategy across the Middle East and Africa region at Haleon. His strategic leadership, cross-functional collaboration, and talent development have been recognised both within and outside the company. Kaskas holds an EMBA in Business Management and Strategy from the prestigious London Business School and has served on several global brand councils, helping guide strategic development and market entry initiatives.
The Hungary/Romania/Czechia/Slovakia cluster, which employs more than 2,000 people, is the largest in terms of sales within Haleon's Central and Eastern Europe region, generating around GBP 680 million in annual sales. Major operations for the cluster are based in Poland and Slovakia, with the region's operations forming a strategic area within Haleon.
Haleon's portfolio includes globally recognised brands such as Sensodyne, Voltaren, Panadol, Advil, Centrum, and Theraflu. The Central and Eastern Europe region covers 34 countries and serves over 284 million consumers. The Hungary/Romania/Czechia/Slovakia cluster contributes significantly to Haleon's overall sales and employee count.
Kaskas is also recognised for his ability to drive growth and brand expansion, having played a key role in successful business turnarounds and profit improvement initiatives. His focus on brand and product innovation is likely to result in the introduction of new, innovative health and wellness products in the region, particularly in the areas of supplements and longevity-related products.
For media inquiries, please visit Haleon's website. The company looks forward to sharing more detailed achievements and updates as Kaskas' tenure progresses and official company statements or reports are released.
In his new role, Kaskas will leverage technology to innovate and expand Haleon's product portfolio in the health and wellness sectors, especially in supplements and longevity-related products. Given the larger sales and employment numbers in the Hungary/Romania/Czechia/Slovakia cluster, this move is strategic towards enhancing Haleon's financial growth in key emerging markets.
